Janney Montgomery Scott
ORMP icon

Janney Montgomery Scott’s Oramed Pharmaceuticals ORMP Stock Holding History

Janney Montgomery Scott’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-12,379
Closed -$149K – 2658
2022
Q4 		$149K Buy
+12,379
New +$96.2K ﹤0.01% 2424
2022
Q1 		– Sell
-23,260
Closed -$332K – 2380
2021
Q4 		$332K Buy
23,260
+2,782
+14% +$58.2K ﹤0.01% 1948
2021
Q3 		$450K Buy
+20,478
New +$349K ﹤0.01% 1720

Other funds holding ORMP

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
SIGI
Susquehanna International Group (Ireland) Dublin, Ireland $472M AUM 25.62% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Janney Montgomery Scott's ORMP Position: Q1 2023 in Review

Janney Montgomery Scott sold out of Oramed Pharmaceuticals (ORMP) in Q1 2023, closing a stake of 12,379 shares — an estimated $149K sold.

Janney Montgomery Scott first reported a position in ORMP in Q3 2021 and held it in 3 quarters. The position peaked at $450K in Q3 2021. 61 funds tracked by Wall St. Rank hold ORMP as of Q1 2023.

  • Janney Montgomery Scott reported no remaining Oramed Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Janney Montgomery Scott sold 12,379 Oramed Pharmaceuticals shares in Q1 2023, an estimated $149K.
  • Janney Montgomery Scott first reported a position in Oramed Pharmaceuticals in Q3 2021 and held it in 3 quarters.
  • Janney Montgomery Scott's Oramed Pharmaceuticals position peaked at $450K in Q3 2021.
  • 61 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q1 2023.

Based on Janney Montgomery Scott's 13F filing for Q1 2023, filed 28 Apr 2023.